MedPath

755nm Alex Laser for Treatment of Stretch Marks

Not Applicable
Completed
Conditions
Striae
Registration Number
NCT01745211
Lead Sponsor
Cynosure, Inc.
Brief Summary

Evaluate the safety and efficacy of the bilateral treatment of striae using a 755nm Alexandrite laser.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Photographic Evaluation of Striae ClearanceFollow Up Between 1 and 3 Months Post Last Treatment

The physician will judge the overall improvement by selecting from improvement ranges of 0-25%, 25-50%, 50-75%, or 75-100% clearance when compared to the baseline.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Laser & Skin Surgery Center of New York

🇺🇸

New York, New York, United States

Laser & Skin Surgery Center of New York
🇺🇸New York, New York, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.